Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US2017051260A1
Chimeric protein toxins for expression by therapeutic bacteria
US9616114B1
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US9739773B1
Compositions and methods for determining successful immunization by one or more vaccines
US9737592B1
Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
US9593339B1
Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
US8623350B1
Protease inhibitor: protease sensitivity expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria
US9200251B1
Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith
US8524220B1
Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US9597379B1
Protease inhibitor combination with therapeutic proteins including antibodies
US8771669B1
Immunization and/or treatment of parasites and infectious agents by live bacteria
US2010135961A1
Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
US2008124355A1
Live bacterial vaccines for viral infection prophylaxis or treatment
